Platelets have been shown to be associated with pathophysiological processes beyond
thrombosis, demonstrating critical additional roles in homeostatic processes, such as …

Many drugs have been implicated in drug-induced immune thrombocytopenia (DITP).
Patients with DITP develop a drop in platelet count 5 to 10 days after drug administration …

We report findings in five patients who presented with venous thrombosis and
thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 …

Historically, the vaccination strategies developed in the second half of the 20th century have
facilitated the eradication of infectious diseases. From the onset of COVID-19 pandemic to …

Background Vaccine‐induced thrombotic thrombocytopenia (VITT) is a rare complication of
adenovirus‐based vaccines aimed to prevent and minimize COVID‐19 and related …

Heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombotic
thrombocytopenia (VITT) are highly prothrombotic (thrombosis frequency≥ 50%). Both are …

Heparin-Induced Thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its
potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis …

A rapid and accurate diagnosis in patients with suspected heparin-induced
thrombocytopenia (HIT) is essential for patient management but remains challenging …

Heparin-induced thrombocytopenia (HIT) is a prothrombotic immune drug reaction caused
by platelet-activating antibodies that in most instances recognize platelet factor 4 …

Thrombocytopenia is a condition characterized by a decreased number of platelets in
peripheral blood, which can be caused by a myriad of both congenital and acquired …